Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The functional roles of the two nucleotide binding folds, NBF1 and NBF2, in the activation of the cystic fibrosis transmembrane conductance regulator (CFTR) were investigated by measuring the rates of activation and deactivation of CFTR Cl- conductance in Xenopus oocytes. Activation of wild-type CFTR in response to application of forskolin and 3-isobutyl-1-methylxanthine (IBMX) was described by a single exponential. Deactivation after washout of the cocktail consisted of two phases: an initial slow phase, described by a latency, and an exponential decline. Rate analysis of CFTR variants bearing analogous mutations in NBF1 and NBF2 permitted us to characterize amino acid substitutions according to their effects on the accessibility and stability of the active state. Access to the active state was very sensitive to substitutions for the invariant glycine (G551) in NBF1, where mutations to alanine (A), serine (S), or aspartic acid (D) reduced the apparent on rate by more than tenfold. The analogous substitutions in NBF2 (G1349) also reduced the on rate, by twofold to 10-fold, but substantially destabilized the active state as well, as judged by increased deactivation rates. In the putative ATP-binding pocket of either NBF, substitution of alanine, glutamine (Q), or arginine (R) for the invariant lysine (K464 or K1250) reduced the on rate similarly, by two- to fourfold. In contrast, these analogous substitutions produced opposite effects on the deactivation rate. NBF1 mutations destabilized the active state, whereas the analogous substitutions in NBF2 stabilized the active state such that activation was prolonged compared with that seen with wild-type CFTR. Substitution of asparagine (N) for a highly conserved aspartic acid (D572) in the ATP-binding pocket of NBF1 dramatically slowed the on rate and destabilized the active state. In contrast, the analogous substitution in NBF2 (D1370N) did not appreciably affect the on rate and markedly stabilized the active state. These results are consistent with a hypothesis for CFTR activation that invokes the binding and hydrolysis of ATP at NBF1 as a crucial step in activation, while at NBF2, ATP binding enhances access to the active state, but the rate of ATP hydrolysis controls the duration of the active state. The relatively slow time courses for activation and deactivation suggest that slow processes modulate ATP-dependent gating.
Abrahams,
Structure at 2.8 A resolution of F1-ATPase from bovine heart mitochondria.
1994, Pubmed
Abrahams,
Structure at 2.8 A resolution of F1-ATPase from bovine heart mitochondria.
1994,
Pubmed Anderson,
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity.
1991,
Pubmed Anderson,
Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains.
1992,
Pubmed Anderson,
Nucleoside triphosphates are required to open the CFTR chloride channel.
1991,
Pubmed Baukrowitz,
Coupling of CFTR Cl- channel gating to an ATP hydrolysis cycle.
1994,
Pubmed Bear,
Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).
1992,
Pubmed Becq,
Possible regulation of CFTR-chloride channels by membrane-bound phosphatases in pancreatic duct cells.
1993,
Pubmed Berger,
Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel.
1991,
Pubmed Carson,
The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.
1995,
Pubmed Carson,
5'-Adenylylimidodiphosphate does not activate CFTR chloride channels in cell-free patches of membrane.
1993,
Pubmed Chang,
Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites.
1993,
Pubmed Cheng,
Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.
1991,
Pubmed Coleman,
Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis.
1994,
Pubmed Cutting,
A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein.
1990,
Pubmed Diamond,
A cross-species analysis of the cystic fibrosis transmembrane conductance regulator. Potential functional domains and regulatory sites.
1991,
Pubmed Drumm,
Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.
1991,
Pubmed
,
Xenbase Drumm,
Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer.
1990,
Pubmed Fischer,
CFTR displays voltage dependence and two gating modes during stimulation.
1994,
Pubmed Fry,
ATP-binding site of adenylate kinase: mechanistic implications of its homology with ras-encoded p21, F1-ATPase, and other nucleotide-binding proteins.
1986,
Pubmed Gregory,
Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2.
1991,
Pubmed Gunderson,
Conformational states of CFTR associated with channel gating: the role ATP binding and hydrolysis.
1995,
Pubmed Gunderson,
Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator channel gating.
1994,
Pubmed Haws,
CFTR in Calu-3 human airway cells: channel properties and role in cAMP-activated Cl- conductance.
1994,
Pubmed Haws,
CFTR channels in immortalized human airway cells.
1992,
Pubmed Hwang,
Functionally distinct phospho-forms underlie incremental activation of protein kinase-regulated Cl- conductance in mammalian heart.
1993,
Pubmed Hwang,
Regulation of the gating of cystic fibrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis.
1994,
Pubmed Hyde,
Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.
1990,
Pubmed Kerem,
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.
1990,
Pubmed Logan,
Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.
1994,
Pubmed Mimura,
Structural model of the nucleotide-binding conserved component of periplasmic permeases.
1991,
Pubmed Minard,
Site-directed mutagenesis of aspartic acid 372 at the ATP binding site of yeast phosphoglycerate kinase: over-expression and characterization of the mutant enzyme.
1990,
Pubmed Müller,
Structure of the complex between adenylate kinase from Escherichia coli and the inhibitor Ap5A refined at 1.9 A resolution. A model for a catalytic transition state.
1992,
Pubmed Rich,
Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R domain.
1993,
Pubmed Riordan,
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
1989,
Pubmed Sadler,
In vivo regulation of cyclic AMP phosphodiesterase in Xenopus oocytes. Stimulation by insulin and insulin-like growth factor 1.
1987,
Pubmed
,
Xenbase Saraste,
The P-loop--a common motif in ATP- and GTP-binding proteins.
1990,
Pubmed Schultz,
Regulation of CFTR Cl- channel gating by ADP and ATP analogues.
1995,
Pubmed Senior,
Further examination of seventeen mutations in Escherichia coli F1-ATPase beta-subunit.
1992,
Pubmed Senior,
Lysine 155 in beta-subunit is a catalytic residue of Escherichia coli F1 ATPase.
1993,
Pubmed Shyamala,
Structure-function analysis of the histidine permease and comparison with cystic fibrosis mutations.
1991,
Pubmed Smit,
Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator.
1993,
Pubmed
,
Xenbase Story,
Structure of the recA protein-ADP complex.
1992,
Pubmed Story,
Structural relationship of bacterial RecA proteins to recombination proteins from bacteriophage T4 and yeast.
1993,
Pubmed Strong,
Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels.
1991,
Pubmed Sung,
Mutation of lysine-48 to arginine in the yeast RAD3 protein abolishes its ATPase and DNA helicase activities but not the ability to bind ATP.
1988,
Pubmed Tabcharani,
Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene.
1991,
Pubmed Thiagalingam,
Both ATPase sites of Escherichia coli UvrA have functional roles in nucleotide excision repair.
1991,
Pubmed Tong,
Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
1991,
Pubmed Tucker,
Identification and developmental expression of the Xenopus laevis cystic fibrosis transmembrane conductance regulator gene.
1992,
Pubmed
,
Xenbase Venglarik,
ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism.
1994,
Pubmed Walker,
Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.
1982,
Pubmed Winter,
Effect of ATP concentration on CFTR Cl- channels: a kinetic analysis of channel regulation.
1994,
Pubmed
